NCM·Healthcare·$2.3B·#148 / 520 in Healthcare
AXGN AxoGen, Inc.
59SPECULATIVE
CATEGORY BREAKDOWN
GROWTH32
QUALITY78
STABILITY84
VALUATION47
GOVERNANCE18
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+20.2%
32
> 50% strong
Gross Margin
Revenue retained after direct costs
74.3%
100
> 50% strong
Cash Runway
Months of cash at current burn rate
999 months
100
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
52.5%
53
< 25% strong
Price / Sales
Market cap relative to trailing revenue
9.5x
47
< 3x strong
Rule of 40
Growth rate plus operating margin
17
45
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
2.0%
16
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+16.2%
21
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE AXGN WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when AXGN's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.